Suppr超能文献

孕期使用精神药物的风险/安全性——2008年母亲风险更新

Risks/safety of psychotropic medication use during pregnancy--Motherisk Update 2008.

作者信息

Einarson Adrienne

机构信息

The Motherisk Program, The Hospital for Sick Children, Toronto, Ontario.

出版信息

Can J Clin Pharmacol. 2009 Winter;16(1):e58-65. Epub 2009 Jan 22.

Abstract

Psychiatric disorders are relatively common among women of childbearing age, who may be prescribed psychotropic drugs. There remains a high level of anxiety regarding their safety among patients and healthcare providers alike, most likely because of the conflicting studies that have been published in the literature and warnings from government organizations. Consequently, treating a psychiatric disorder during pregnancy with pharmacotherapy, is a complex decision making process, which has to be made between the pregnant woman and her healthcare provider. The objective of this brief review is to discuss the current models for studying the use of drugs in pregnancy and to provide current information on the safety/risk of psychotropic drugs used in pregnancy. The body of evidence in the literature to date suggests that psychotropic drugs as a group are relatively safe to take during pregnancy and women and their health care providers should not be unduly concerned if a woman requires treatment. Optimal control of the psychiatric disorder should be maintained during pregnancy, the post partum period and thereafter.All pregnancies where a mother has a serious psychiatric disorder should be considered high risk and the mother and fetus must be carefully monitored.

摘要

精神疾病在育龄女性中相对常见,她们可能会被开精神类药物。患者和医疗服务提供者对这些药物的安全性都高度焦虑,这很可能是因为文献中发表的相互矛盾的研究以及政府组织发出的警告。因此,在孕期使用药物疗法治疗精神疾病是一个复杂的决策过程,必须由孕妇及其医疗服务提供者共同做出。这篇简短综述的目的是讨论目前研究孕期用药的模式,并提供有关孕期使用精神类药物的安全性/风险的最新信息。迄今为止,文献中的证据表明,作为一个整体,精神类药物在孕期服用相对安全,如果女性需要治疗,女性及其医疗服务提供者不应过度担忧。在孕期、产后及之后,都应维持对精神疾病的最佳控制。所有母亲患有严重精神疾病的妊娠都应被视为高危妊娠,必须对母亲和胎儿进行仔细监测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验